Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.
He has an MA from University of Sioux Falls. You can connect with Jared on LinkedIn.
Field Study Highlights Differences in Factor IX Variant Lab Results
Different types of assays led to different results in measures of factor IX variant FIX-R338L, the authors found.
In Patients With Hemophilia A, Physical Activity Levels Low
A new study also found a lack of correlation between physical activity levels and bleeding episodes among people with hemophilia A.
HMA Therapy Translates to More Time at Home for Patients With AML
People receiving hypomethylating agent (HMA) therapy spent 33 more days at home than people receiving anthracycline-based therapy in the first year after diagnosis.
More People With T1D Are Living Into Old Age
A new prevalence study shows more people are living beyond age 65 with type 1 diabetes (T1D).
Community Practitioner–Led Hypertension Program Yields Strong Results
A Chinese study shows hypertension management led by nonphysicians can be safe and effective.
Emicizumab Has Strong Safety, Efficacy Record in Real-World Usage
The most common treatment-related adverse events were injection site reactions, the study found.
Case Highlights Difficulties Identifying MG Secondary to ICI Therapy
There currently are no guidelines on how to treat this patient group, despite a high risk of mortality.
Gender May Affect Whether, Why Patients With T1D Exercise
Men are less likely than women to desire community when exercising, the authors found.
Real-World Database Yields New Potential Safety Signals for Bendamustine
The authors said their analysis should help clinicians better monitor patients for potential adverse events.
Consortium: PROs Have Key Role in MDS Trials
The coalition said, however, that patient-reported outcomes (PROs) in the myelodysplastic syndrome (MDS) space will be most meaningful if they are collected rigorously and if the data are transparent.
Long-Term Analysis From DUO Trial Affirms Benefits of Duvelisib
The new data shed light on long-term outcomes for patients receiving duvelisib, although the investigators said the treatment landscape has also shifted significantly since the original trial.
Case Report Finds SSRIs Work Alongside MG Therapy in Teen Patient
The report found a selective serotonin reuptake inhibitor (SSRI) did not offset the effects of myasthenia gravis (MG) medication.
Study Identifies New Links Between Monocytes, T1D Progression
A new report builds on previous research that could help scientists better understand type 1 diabetes (T1D) risk.
Hemophilia Not Linked With Cognitive and Behavioral Outcomes in Children
However, investigators said there is some evidence suggesting attention-deficit/hyperactivity disorder may be more common in certain age groups of children with hemophilia.
Case Report: Abducens Nerve Palsy Could Be Sign of Myasthenia Gravis
A 68-year-old man was diagnosed with ocular myasthenia gravis after presenting with double-vision and photophobia.
SID Heightens Infection Risk in Patients With B-Cell Malignancies
A new report finds secondary immunodeficiency disease (SID) also increases the risk of mortality in patients with B-cell malignancies.
Gene Therapy Offers Promise in Treating Inborn Errors of Immunity
A new report says early evidence of using gene therapy to treat monogenic diseases offers reason for optimism.
Closed-Loop Glucose Management Improves Outcomes in Youth With T1D
Patients with type 1 diabetes (T1D) reported improved glucose outcomes, but they also said their sleep and quality of life benefited.
Exercise-Induced Hypertension a Risk Factor for Sudden Cardiac Death, Review Finds
The findings show exercise-induced hypertension increases myocardial oxygen demand.
Study: Care Costs for R/R DLBCL Increase With Each Line of Therapy
New therapies are helping patients, but are also driving up overall costs of care.
Case Report Demonstrates Nuanced Decisions in Treating ALL Relapse With Skull Base Lesion
Physicians treated the patient without surgery, although they said the patient’s case is particularly challenging and treatment was ongoing at the time of the report’s writing.
Extension Trial Shows Zilucoplan Safe and Effective for MG at 60 Weeks
COVID-19 and worsening myasthenia gravis (MG) were the most common treatment-emergent adverse events, the study found.
Machine Learning and Neural Network Can Be Effective Diagnostic Tools in MDS, Study Finds
The investigators said their new system makes it possible for researchers to leverage artificial intelligence even if they do not have expertise working with advanced software.
AE Analysis Finds Low Rate of T-Cell Malignant Neoplasms in CAR T Recipients
Only 11 cases of adverse events (AEs) were reported over a 6-year time frame, the investigators found, following administration of chimeric antigen receptor T-cell therapy (CAR T).
Review Finds Anti-BCMA CAR T-Cell Therapy Effective in Patients With MM
The analysis also found the therapy has a manageable safety profile.
Long-Term Data Demonstrate Emicizumab Safety, Efficacy in Hemophilia A
The therapy bridges activated factors IX and X to mimic the function of missing or deficient factor VIII.
Long-Term Data Affirm Efficacy of Eculizumab in Refractory Generalized MG
A new survey has found that most patients who have generalized myasthenia gravis who switched from eculizumab to ravulizumab preferred the latter.
Improving Cancer Care: The Role of Oral Hypomethylating Agents and Education
Investigators say oral formulations of hypomethylating agents could be a significant advancement for people with myelodysplastic syndromes and acute myeloid leukemia.
Nonpharmacological Approaches Lead to Significant Alleviation of CLL-Associated Fatigue
Investigators said both reflexology and acupressure led to similar improvement in patients after 4 weeks.
Uncontrolled Type 1 Diabetes Linked With MASLD Risk in Pediatric Patients
Previous research links type 2 diabetes and metabolic dysfunction–associated steatotic liver disease (MASLD).